INOVIO Pharmaceuticals
NEWS ALERT

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Press Releases

INOVIO to Present at Upcoming Scientific Conferences

Posted on October 1, 2024

INOVIO to Present at Upcoming Scientific Conference

Posted on September 17, 2024

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Posted on August 8, 2024

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Posted on July 25, 2024

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

Posted on July 25, 2024

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government’s Innovative Licensing and Access Pathway

Posted on July 11, 2024

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

Posted on July 2, 2024

INOVIO Added to Russell 2000® Index Effective July 1, 2024

Posted on July 1, 2024

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

Posted on June 4, 2024

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights

Posted on May 13, 2024

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.